Alterna Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-914
Closed -$203K 74
2023
Q2
$203K Buy
914
+33
+4% +$7.66K 0.24% 99
2023
Q1
$213K Sell
881
-48
-5% -$11.8K 0.27% 88
2022
Q4
$244K Hold
929
0.27% 66
2022
Q3
$209K Buy
929
+96
+12% +$23.3K 0.25% 67
2022
Q2
$203K Buy
+833
New +$204K 0.21% 75
2019
Q1
Sell
-6,416
Closed -$1.1M 115
2018
Q4
$1.1M Buy
+6,416
New +$1.25M 0.18% 88

Other funds holding AMGN

Alterna Wealth Management's AMGN Position: Q3 2023 in Review

Alterna Wealth Management sold out of Amgen (AMGN) in Q3 2023, closing a stake of 914 shares — an estimated $203K sold.

Alterna Wealth Management first reported a position in AMGN in Q4 2018 and held it in 6 quarters. The position peaked at $1.1M in Q4 2018. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Alterna Wealth Management reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Alterna Wealth Management sold 914 Amgen shares in Q3 2023, an estimated $203K.
  • Alterna Wealth Management first reported a position in Amgen in Q4 2018 and held it in 6 quarters.
  • Alterna Wealth Management's Amgen position peaked at $1.1M in Q4 2018.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Alterna Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.